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Please use the following codes to evaluate: 1 = Strongly Disagree   2 = Disagree   3 = Neutral   4 = Agree   5 = Strongly Agree
Educational Objectives
Indicate on a scale from 1 to 5 the extent to which this activity met your expectations.
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Please use the following codes to evaluate: 1 = Strongly Disagree   2 = Disagree   3 = Neutral   4 = Agree   5 = Strongly Agree
Activity Effectiveness
Commercial Support and Disclosure
If you answered "No" to any of the above, please provide details:
Participant History
Please use the following codes to evaluate: 1 = Needs Improvement   2 = Below Average   3 = Average   4 = Above Average   5 = Excellent
Discuss the use of predictive markers to direct selection of chemotherapeutic agents for the treatment of NSCLC.
Evaluate the use of molecular profiling to predict clinical outcomes in the adjuvant setting for patients with NSCLC.
Describe the rationale for using molecular markers to individualize treatment for patients with NSCLC. 1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
My preferred educational format is: Number of CME-accredited articles read annually:
0-5 6-10 11-15 16-20 >20Symposium/conference/workshop
Online activity
Satellite broadcast
CD-ROM/DVD
Monograph/journal supplement
Podcast
PDA CME
Addressed competencies identified by my specialty.
Addressed barriers to my optimal patient management.
Applied trial data to patients I see in my practice.
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
Yes No Comments
Disclosures of faculty relationships or affiliations with commercial organizations
were made available to me before this activity.
The commercial supporter was acknowledged.
Compared with all other activities that I have reviewed over the past year, I would rate this activity as:
0%-20% 21%-40% 41%-60% 61%-80% 81%-100%
What percentage of the content of this activity was new to you?
Content was current and up to date.
My competence level was increased as a result of this activity.
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
Major strengths of the activity:
Major weaknesses of the activity:
Indicate on a scale from 1 to 5 the extent to which you agree that the activity met the following educational objectives.
Activity Expectations
Addressed my most pressing questions.
Provided clear evidence to support content.
1 2 3 4 5
1 2 3 4 5
Discuss the use of molecular markers to refine the use of targeted agents for the treatment of NSCLC. 1 2 3 4 5
Describe data supporting the use of clinical prognostic and predictive factors for patients with NSCLC receiving
targeted therapies. 1 2 3 4 5
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Educational Inquiries
For further information, please contact the CBCE, 1707 Market Place Blvd., Suite 370, Irving, TX 75063; Phone: (214) 260-9024;
Fax: (214) 260-0509; E-mail: info@thecbce.com.
If you wish to receive credit for this activity, please complete and
submit this form to the CBCE.
E-mail Fax
Signature
Specialty
City State Zip Code
Phone Number
Fax Number
E-mail
I participated in the entire activity and claim
1.25 AMA PRA Category 1 Credits    .
I participated in only part of the activity
 and claim partial credit hour based on
_______hour of instruction (eg, 0.75, 1.0).
You have permission to contact me in approximately 6-8
weeks to determine if I was able to implement changes in my
practice as a result of this activity. Contact me by:
I would like to receive information about future CBCE
activities.
I certify that the above is true and correct.
Name
Work HomeThe following address is my:
Country
CME: Credentials
TM
Organization
Date
Street Address
Activity Outcomes Measurement
Please use the following codes to evaluate: 1 = No Change  2 = Little Change  3 = May Change  4 = Some Change  5 = Will Change
Do you expect your management strategies in this clinical area to change within the next 6 months as a
result of participating in this activity? 1 2 3 4 5
1 2 3 4 5To what extent could this activity improve your patient care/outcomes?
Future Educational Needs
Please list any other topics or delivery formats you would like to see in future educational activities:
Do you have any suggestions for improving this or future activities?
Request for Credit Form
State a change you are committed to making in your practice based on the objectives of this activity:
CNE: I participated in the entire activity and claim
1.25 nurse contact hours.
CPE: I participated in the entire activity and claim
1.25 pharmacy contact hours.
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